Upstate Active Clinical Trials
Study Title:Pilot study of the safety and feasibility of administering concurrent systemic chemotherapy with accelerated hypofractionated radiation therapy in the treatment of medically inoperable T1b and T2 Non-Small Cell Lung Cancer
What is the purpose of the study?To assess safety and tolerability of concurrent chemotherapy with hypofractionated radiation therapy for T1b, T2a and T2b non-small cell lung cancer. This will serve as a pilot study in designing further trials to compare this to the current standard of care which does not routinely involve systemic chemotherapy for cancer of this stage. The primary endpoint will be to assess the rate of toxicity of the therapy.
Upstate Institutional Review Board (IRB) Number:665895
Patient Age Group:Adults
Principal Investigator:Michael D Mix, MD
What is involved if I participate?
- What tests and procedures are involved?
Upstate Cancer Center - all procedures
The Hill Medical Center - all procedures
Oswego - all procedures
Oneida - all procedures
Who can I contact for more information?
Name: Erin Bingham